Brief: Amphastar Pharmaceuticals Receives FDA Approval For Dextrose Injection
29/03/2021 12:24
March 29 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O :
* AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR
DEXTROSE
INJECTION
Source text for Eikon: ID:nGNXCHFvl
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing